Settore

Drug development, clinical phases

5 bandi attivi in questo settore.

Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses

Ricerca e sviluppo Finanziamento agevolato Imprese / PMI

Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing dise…

13 apr 2027

EU Funding Aperto

Development of innovative antimicrobials against pathogens resistant to antimicrobials

Commissione Europea

Ricerca e sviluppo Finanziamento agevolato Imprese / PMI

Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing dise…

13 apr 2027

EU Funding Aperto

Development of monoclonal antibodies to prevent and treat infections from Flaviviruses

Commissione Europea

Ricerca e sviluppo Finanziamento agevolato Imprese / PMI

Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing dise…

13 apr 2027

EU Funding Aperto

Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential

Commissione Europea

Ricerca e sviluppo Finanziamento agevolato Imprese / PMI

Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing dise…

13 apr 2027

EU Funding Aperto

European Partnership for Pandemic Preparedness (Phase 2)

Commissione Europea

Ricerca e sviluppo Finanziamento agevolato Imprese / PMI

Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing dise…

13 apr 2027